This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Itm Isotope Technologies Munich Se, Paul Scherrer Institut. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 121 
Years Active: 2023
Title: Christoph Umbricht: Innovator in Radiopharmaceuticals
Introduction
Christoph Umbricht is a notable inventor based in Baden, Switzerland. He has made significant contributions to the field of radiopharmaceuticals, particularly in the development of compounds that aid in cancer treatment and imaging.
Latest Patents
Umbricht holds a patent for PSMA-binding agents and their uses. This invention provides novel compounds that are useful as radiopharmaceuticals, imaging agents, and for the treatment of cancer. His innovative work in this area has the potential to enhance diagnostic and therapeutic options for patients.
Career Highlights
Throughout his career, Christoph Umbricht has worked with prominent organizations such as ITM Isotope Technologies Munich SE and the Paul Scherrer Institute. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Umbricht has collaborated with talented individuals, including Martina Benesova and Cristina Müller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Christoph Umbricht's work in the field of radiopharmaceuticals exemplifies the impact of innovative thinking on cancer treatment. His contributions continue to pave the way for advancements in medical technology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile